TF
AGN

TimeScale Financial’s Allergan plc AGN Stock Holding History

TimeScale Financial’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-36
Closed -$6K – 490
2020
Q1 		$6K Hold
36
– – ﹤0.01% 328
2019
Q4 		$6K Hold
36
– – ﹤0.01% 418
2019
Q3 		$6K Hold
36
– – ﹤0.01% 394
2019
Q2 		$6K Buy
+36
New +$4.99K ﹤0.01% 409

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

TimeScale Financial's AGN Position: Q2 2020 in Review

TimeScale Financial sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 36 shares — an estimated $6K sold.

TimeScale Financial first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $6K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • TimeScale Financial reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • TimeScale Financial sold 36 Allergan plc shares in Q2 2020, an estimated $6K.
  • TimeScale Financial first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • TimeScale Financial's Allergan plc position peaked at $6K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on TimeScale Financial's 13F filing for Q2 2020, filed 3 Aug 2020.